Aridis Pharmaceuticals, Inc. License Agreements
5 Contracts & Agreements
- Amendment No. 1 to the License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated August 9, 2021 (Filed With SEC on August 12, 2021)
- License Agreement between Medimmune Limited and Aridis Pharmaceuticals, Inc. dated as of July 12, 2021 (Filed With SEC on July 19, 2021)
- Exclusive License Agreement dated September 10, 2020 by and between Aridis Pharmaceuticals, Inc. and UAB Research Foundation (Filed With SEC on November 23, 2020)
- License, Development and Commercialization Agreement between Aridis Pharmaceuticals, Inc. and Serum AMR Products, entered into as of September 27, 2019 (Filed With SEC on October 3, 2019)
- Option Agreement for Exclusive Product and Platform Technology License between Aridis Pharmaceuticals, Inc. and Serum International BV, dated July 16, 2019 (Filed With SEC on July 30, 2019)
